Background
==========

Postoperative pulmonary infection is a common complication after major cardiac surgery, with high morbidity and mortality \[[@b1-medscimonit-25-3077],[@b2-medscimonit-25-3077]\]. About 3--42% patients reported to be diagnosed as pneumonia after cardiac surgery had significant higher fatality rate \[[@b1-medscimonit-25-3077]\]. Pneumonia after coronary artery bypass grafting (CABG) is associated with 4-fold higher death rate and about 3-fold longer duration of hospitalization compared to patients without it \[[@b1-medscimonit-25-3077]\]. More than a quarter of patients who need CABG were older than 70 years of age \[[@b2-medscimonit-25-3077]\]. The rapidly growing proportion of the older patients is often accompanied by the increasing incidence of postoperative pneumonia \[[@b3-medscimonit-25-3077],[@b4-medscimonit-25-3077]\].

Current diagnosis and validation of postoperative pneumonia require a combination of many factors, such as chest roentgenogram, white blood cells (WBC), neutral granulocyte ratio, and body temperature, and their measurements often lagged behind the actual occurrence of the condition (not determined in early stage) \[[@b5-medscimonit-25-3077]\]. The hysteresis of traditional diagnostic methods could delay the treatment, thus hindering postoperative recovery and increasing mortality. Therefore, it is of great significance to develop a more accurate and effective method in diagnosing early postoperative pneumonia (EPOP). Procalcitonin (PCT) is a widely-recognized clinical marker of bacterial infection \[[@b3-medscimonit-25-3077]\]. We attempted to evaluate the effectiveness and feasibility of PCT in diagnosing EPOP after off-pump CABG in comparison PCT with traditional diagnostic methods.

Material and Methods
====================

Ethics statement
----------------

Written inform consents were obtained from all enrolled patients before applying the clinical records. All protocols adopted here were approved by the Ethics Committee at East Hospital (ID: 2017-043) with the clinical trial registration number ChiCTR-RRC-17014055.

Patients
--------

Of the 578 patients undergoing CABG between January 2015 and July 2017 in our department, 402 patients were eventually enrolled in this retrospective observational study. The inclusion criteria were as follows: age \>18 years old, first-time isolated off-pump CABG, and normal liver and kidney function before operation. Exclusion criteria were as follows: severe and prolonged cardiogenic shock, preoperative use of glucocorticoids or large-dose antibiotics, preoperative infection disease (including pneumonia), autoimmune disease, carcinoma and malnutrition, death within 3 days after surgery, or incomplete clinical data.

Prior to intubation, all patients routinely took antibiotics every 4 hours during the operation and every 8 hours after the operation until 24 hours later.

After surgical revascularization, patients were routinely transferred to and treated for 1 to 3 days in the intensive care unit (ICU). Following continued mechanical ventilation for 6 to 12 hours and with adequate breathing measurements, all patients were extubated with an uneventful course.

Definition of early postoperative pneumonia (EPOP)
--------------------------------------------------

This study focused on patients diagnosed as pneumonia within 3 days after off-pump CABG. EPOP was based on one chest roentgenogram change (new or progressive and persistent infiltration; consolidation; or cavitation) within 72 hours after operation associated with at least one of the following characteristics \[[@b6-medscimonit-25-3077],[@b7-medscimonit-25-3077]\]: 1) fever (\>38°C) with no other recognized cause; 2) leucopenia (\<4000 WBCs/mm^3^) or leukocytosis (\>12 000 WBCs/mm^3^); 3) purulent secretion; 4) positive bacteriology tests for sputum.

Definition of systemic inflammatory response syndrome (SIRS)
------------------------------------------------------------

SIRS was based on the widely-used definition by Muckart and Bhagwanjee. SIRS was defined as no sign of infection and characterized by the presence of at least 2 of the following 4 criteria: 1) body temperature \>38°C (\>100.4°F) or \<36°C (\<96.8°F); 2) heart rate \>90 beats/min; 3) respiratory rate \>20 breaths/min or partial CO~2~ pressure (pCO~2~) \<32 mmHg (\<4.3 KPa), or need for mechanical ventilatory support; 4) WBC \>12 000/μL or \<4000/μL; or \>10% immature forms.

Data collection and biological measurements
-------------------------------------------

Demographic characteristics and clinical data were provided by a computerized database of the hospital. Venous blood was routinely sampled for detection of PCT in the morning of postoperative day (POD1) PCT concentration was detected by electrochemiluminescence assay with a Roche Cobas E602 analyzer in accordance with manufacture's instruction in the central laboratory of hospital. The range of the PCT assay was 0--100 ng/mL, and the reference range was 0--0.05 ng/mL (analytic sensitivity=0.001 ng/mL). WBC and neutral granulocyte ratio were measured for at least 3 days after operation. Body temperature was first measured every hour within 8 hours after operation (or every 3 hours until 3 times of temperature measurements were all normal) and then once a day. Chest roentgenogram was usually examined at noon on POD1 and POD2, and then tested again according to patient's condition. Sputum bacteriology test was implemented at noon on POD1 as an ICU routine. Acute Physiology and Chronic Health Evaluation II (APACHE II) score was determined within the first 5 hour to the ICU.

Statistical analysis
--------------------

Continuous variables were expressed as mean ± standard deviation, while categorical variables as number and percentage. If the data were normally distributed, Student's *t*-test (significance level=0.05) and Leven's test (significance level=0.2) were applied in statistical analysis; otherwise, between-group comparison was performed by the Mann-Whitney U test, with significant level at *P*\<0.05. The calculations above were conducted on SPSS 22.0 (IBM, Chicago, IL, USA).

Serum PCT, WBC, neutral granulocyte ratio, and body temperature at POD1 were numerical data collected to calculate diagnostic accuracy by receiver operating characteristic (ROC) analyses and clinical practicability by decision curve analysis (DCA). The area under the ROC curve (AUC) was calculated for diagnostic accuracy of each tested variation according to the Delong test. The net benefit of PCT; WBC; neutral granulocyte ratio, and body temperature were analyzed after jointing baseline in the way of DCA weighed by the relative harm of a false-positive and false-negative result. DCA was conducted on R software 3.4.0 (The R Foundation for statistical computing, Jersey, Austria) with package Decision curve.

Results
=======

Demographic data and patient characteristics
--------------------------------------------

The 402 patients were aged 64.71±8.72 years old (37 to 86 years old) ([Table 1](#t1-medscimonit-25-3077){ref-type="table"}). Among them, 44 patients (10.95%) were diagnosed as EPOP and 112 (27.86%) patients as SIRS.

The concentration of PCT was 1.50±2.98 ng/mL in total cohort. From the whole view of WBC level fluctuation in blood, the concentration at POD1 was 15.18±3.90×10^3^/ul, culminated at POD2 (17.19+4.67×10^3^/uL) and declined at POD3 (14.52±4.39×10^3^/uL). Neutral granulocyte ratio together with body temperature within 3 days after operation are showed in [Table 1](#t1-medscimonit-25-3077){ref-type="table"}.

The perioperative data of EPOP group and non-EPOP group are exhibited in [Table 2](#t2-medscimonit-25-3077){ref-type="table"}. PCT serum levels were much higher in the EPOP group than the non-EPOP group (5.21±7.15 versus 1.04±1.39 ng/uL, *P*\<0.001). The hospital mortality in the EPOP group was also significantly higher (9.09% versus 1.96%, *P*=0.006). Eleven patients (2.7%) including 4 with and 7 without pneumonia died at POD5-17. The 4 EPOP patients died of respiratory failure (3 patients) or malignant arrhythmia (1 patient), while the 7 non-EPOP patients died of heart failure (3 patients), myocardial infarction (2 patients) or malignant arrhythmia (2 patients). However, during the first 3 days after operation, neither WBC level nor body temperature varied largely between the groups. The qualitative results for sputum bacteriology tests shown in [Supplementary Table 1](#s1-medscimonit-25-3077){ref-type="supplementary-material"} represented different bacteria in the respiratory system, including oral cavity.

Diagnostic value of PCT for EPOP
--------------------------------

According to the ROC curves in [Figure 1A](#f1-medscimonit-25-3077){ref-type="fig"} and calculations in [Table 3](#t3-medscimonit-25-3077){ref-type="table"}, the AUC of PCT at POD1 was 0.808 and the cutoff value was about 1.585 ng/mL with sensitivity of 73% and specificity of 86%, indicating the underlying considerable diagnostic value of PCT. The AUCs of WBC, neutral granulocyte ratio, and body temperature from POD1 to POD3 were all worse than PCT along with less optimistic cutoff value and sensitivity. The specificity of WBC at POD1 or POD3 and body temperature at POD2 were relatively high (95%, 92%, and 97%, respectively), but none of the sensitivity was satisfying (14%, 16%, and 5%, respectively).

DCA was conducted to analyze the clinical benefits of different molecules in diagnosing EPOP after off-pump CABG in the validation dataset. The WBC, neutral granulocyte ratio, and body temperature showed very close decision curves, regardless of the threshold selected, and their net benefits were significantly smaller than PCT between 5% and 95% ([Figure 2A](#f2-medscimonit-25-3077){ref-type="fig"}).

Diagnostic value of PCT in SIRS patients
----------------------------------------

The 402 patients were divided into a SIRS group and a non-SIRS group ([Supplementary Table 2](#s1-medscimonit-25-3077){ref-type="supplementary-material"}), which involved 13 and 31 EPOP patients, respectively. [Figure 1B and 1C](#f1-medscimonit-25-3077){ref-type="fig"} present AUCs of PCT, WBC, neutral granulocyte ratio, and body temperature, and [Table 4](#t4-medscimonit-25-3077){ref-type="table"} summarizes the calculations according to the AUC and validation dataset. In the SIRS group, PCT performed better with AUC of 0.868 (95% CI 0.748--0.988), cutoff value of 1.775 ng/mL, sensitivity of 85% and specificity of 89%. In the non-SIRS group, PCT performed better with AUC of 0.784 (95% CI 0.680--0.889), cutoff value of 1.580 ng/mL, sensitivity of 68% and specificity of 86%.

In the SIRS group, the decision curves of WBC, neutral granulocyte ratio, and body temperature also remained close regardless of the threshold selected, but their net benefits were significantly fewer than PCT between 5% and 100% ([Figure 2B](#f2-medscimonit-25-3077){ref-type="fig"}). In the non-SIRS group, PCT was not superior over the other 3 methods, and the 4 decision curves remained close regardless of the threshold selected ([Figure 2C](#f2-medscimonit-25-3077){ref-type="fig"})

Discussion
==========

PCT is widely acknowledged as a valuable marker of inflammatory response after cardiac surgery \[[@b8-medscimonit-25-3077]\]. The serum PCT concentration is very low among non-infected healthy people (\<0.05 ng/mL), but could be remarkably increased by about 10-fold by bacterial infection instead of other organism infection \[[@b9-medscimonit-25-3077]\]. After injection of bacterial endotoxin, the serum PCT level in healthy people could increase within 3 to 4 hours and exceed the maximum by about 1700-fold within 24 hours \[[@b10-medscimonit-25-3077]\]. PCT level reflects the response activity of systemic inflammation and is affected by the size and types of infected organs, bacterial species, degree of inflammation and immune response \[[@b11-medscimonit-25-3077]\]. However, the PCT levels in these cases probably induced by the release of cytokines or bacterial shifting from the gut are significantly lower than those with bacterial infection \[[@b12-medscimonit-25-3077]\].

CABG is the most common cardiac surgery and the largest number of operations performed in cardiac surgery. Contact of the blood with the surface of artificial extracorporeal circulation pipeline in on-pump CABG can induce systemic inflammatory response in the blood mediated by abundant secretion of inflammatory factors. The infectious markers are sensitive to inflammation after cardiac surgery, which needs extracorporeal circulation. Off-pump CABG has become a commonly used bypass method because it is more beneficial for patients as it avoids additional myocardial injury, inflammatory reaction and influence on blood flow dynamics \[[@b13-medscimonit-25-3077]\]. The off-pump pattern is more commonly used in China \[[@b14-medscimonit-25-3077]\]. Moreover, the aging problem of coronary artery disease patients is a concern in developing countries (e.g., China) in addition to developed countries. In this study, 31.3% of the patients were older than 70 years old. Therefore, pneumonia still frequently occurred after off-pump CABG, accompanied by the increasing proportion of older patients \[[@b15-medscimonit-25-3077]\]. Patients with pneumonia were likely to have a prolonged postoperative hospital stay and higher risk of mortality \[[@b1-medscimonit-25-3077]\]. In our study, the incidence of EPOP was 10.95% and the mortality of EPOP patients was significantly higher than the non-EPOP patients.

Diagnosis of EPOP could benefit the prognosis by shortening the ICU stay time and eventually guide early risk stratification and antibiotic application \[[@b16-medscimonit-25-3077]\]. However, early diagnosis of infectious complications is still difficult for patients assigned to ICU after cardiac surgery \[[@b17-medscimonit-25-3077]\]. Chest roentgenogram examination is necessary for diagnosis of postoperative pneumonia, but is not sufficient and should be supplemented by other indicators. Traditional infectious markers including leukocytes, neutral granulocyte ratio, and body temperature are valuable in diagnosis of delayed complications, but are hindered in diagnosing EPOP for their prolonged accumulation to peak level \[[@b5-medscimonit-25-3077]\].

In the past decade, PCT has been studied during ICU stays after cardiac surgery as a diagnostic monitoring of bacterial infection, and could be used as an early marker to differentiate inflammation with or without bacterial infection and to evaluate clinical course or prognosis of inflammatory disease \[[@b16-medscimonit-25-3077]\]. As reported, the increased serum PCT levels after CABG are correlated with infectious complications \[[@b18-medscimonit-25-3077]\]. The PCT level elevation induced by endotoxin after bacterial infection can be summarized in 2 phases \[[@b10-medscimonit-25-3077]\]: first, the PCT level elevates quickly mainly due to endotoxin stimulation within 2 to 4 hours after infection; second, serum PCT increases more rapidly and maximizes in the next 6 to 8 hours mainly due to synthesis and release of inflammatory factors from multiple tissues out of thyroid, which sustains for 24 hours in the body and has a half-life of 18 hours to 24 hours. Therefore, we tested serum PCT at POD1 to investigate its correlation with EPOP.

In the present study, the serum PCT level at POD1 and neutral granulocyte ratios at POD2 and POD3 in the EPOP group were all significantly higher than in the non-EPOP group. However, the cutoff value of PCT in diagnosing EPOP exceeds 1.585 ng/mL with sensitivity of 73% and specificity of 86%, and its diagnostic value is reliable and superior over body temperature, WBC, and neutral granulocyte ratio. The diagnosis of EPOP based on serum PCT is earlier and more accurate than other traditional markers according to ROC analysis. Overall, the composite expression for PCT in diagnosing EPOP and in clinical use is relatively superior over the 3 traditional diagnostic markers.

Serum PCT is an important index of bacterial infection with great guiding effects on antibiotics choice in the early stage for infection \[[@b16-medscimonit-25-3077]\] and smart reflection of the severity and long-term prognosis \[[@b19-medscimonit-25-3077]\], and thus is useful in diagnosis of postoperative SIRS after CABG. As has been reported, the PCT levels were different between the severe SIRS group and the control group, but not between the SIRS patients and the non-SIRS patients \[[@b20-medscimonit-25-3077]\]. The incidence of SIRS in our study was 27.86%. Our analysis suggests PCT has no value in diagnosing SIRS, which is in accordance with the literatures aforementioned. Our patients did not have severe SIRS. The degree of systemic inflammatory response without cardiopulmonary bypass was also reduced compared with on-pump cardiac surgery \[[@b21-medscimonit-25-3077]\]. Therefore, PCT was not different between SIRS and non-SIRS groups. However, the diagnosis of EPOP after off-pump CABG was extremely accurate especially in SIRS patients. The cutoff value of PCT in predicting EPOP in the SIRS group was 1.775 ng/mL with sensitivity of 85% and specificity of 89%, indicating PCT is valuable for infection diagnosis in more complex complications.

Although PCT is valuable in diagnosing infection after cardiac surgery, the cutoff value is not consistent, as it is affected by the types of surgical procedures used among different medical centers. As previously reported, PCT had a cutoff value of 4 ng/mL, sensitivity of 86% and specificity of 98% in predicting infection among 59 CPB-treated patients \[[@b22-medscimonit-25-3077]\]. The level of PCT (\>2 ng/mL) had a sensitivity of 83% and a specificity of 75% in infection discrimination \[[@b23-medscimonit-25-3077]\]. In the present study, the cutoff point of PCT in predicting EPOP was 1.585 ng/mL, but rose to 1.775 ng/mL in the SIRS group. Although the cutoff values were different, the increasing PCT levels were consistent with the postoperative infection.

DCA is a predictive model widely used in clinical decision-making to evaluate the accuracy of diagnostic methods \[[@b24-medscimonit-25-3077]\]. Unlike ROC analysis which only concerns the accuracy from the perspectives of specificity and sensitivity, DCA developed by Vickers et al. concerns the net benefits and has greater clinical value \[[@b25-medscimonit-25-3077]\]. In our study, DCA was proved a convincing clinical method for PCT in diagnosing EPOP both in total cohort and in SIRS group regardless of the threshold selected.

Limitations
-----------

Firstly, this retrospective monocentric survey had no long-term follow-up for these patients. Secondly, the sample size was small, which should be supplemented by larger sample of patients. Thirdly, this study was focused only on EPOP patients who had undergone off-pump CABG. Fourthly, this study was limited by the discrepancy between the EPOP and non EPOP cohorts.

Conclusions
===========

PCT is an available and valuable marker in distinguishing early pneumonia for off-pump CABG. The diagnosing accuracy of PCT is higher than traditional methods. PCT also show satisfactory performance on diagnosing EPOP in SIRS patients.

Supplementary Tables
====================

###### 

Comparison of bacterium detected in EPOP and non EPOP groups.

  -------------------------------------------------------------------
  Organism                            EPOP group\   Non EPOP group\
                                      N=44          N=358
  ----------------------------------- ------------- -----------------
  Gram positive coccus                1 (2.27%)     15 (4.19%)

  Gram negative bacilli               16 (36.36%)   134 (37.43%)

  *Klebsiella pneumoniae*             7 (15.91%)    12 (3.35%)

  *Baumanii*                          9 (20.45%)    6 (1.68%)

  *Candida albicans*                  1 (2.27%)     1 (0.28%)

  Fungal spore                        2 (4.55%)     3 (0.84%)

  *Pseudomonas aeruginosa*            5 (11.36%)    7 (1.96%)

  *Streptococcus pneumoniae*          0 (0.00%)     2 (0.56%)

  *Haemophilus influenzae*            0 (0.00%)     2 (0.56%)

  *Hemophilus parainfluenzae*         0 (0.00%)     2 (0.56%)

  *Candida glabrata*                  0 (0.00%)     1 (0.28%)

  *Aerobacter cloacae*                2 (4.55%)     2 (0.56%)

  *Bacillus prodigiosus*              1 (2.27%)     2 (0.56%)

  *Enterobacteriaceae Ludwig*         0 (0.00%)     1 (0.28%)

  *Morganella morganii*               0 (0.00%)     1 (0.28%)

  *Raoultella ornithinolytica*        0 (0.00%)     1 (0.28%)

  *Streptococcus agalactiae*          0 (0.00%)     1 (0.28%)

  *Staphylococcu*s human subspecies   0 (0.00%)     1 (0.28%)

  *Enterobacter aerogenes*            1 (2.27%)     0 (0.00%)

  *Escherichia coli*                  2 (4.55%)     0 (0.00%)

  *Staphylococcus aureus*             2 (4.55%)     0 (0.00%)

  Coagulase negative staphylococcus   1 (2.27%)     0 (0.00%)

  *Moraxelle catarrhalis*             0 (0.00%)     1 (0.28%)
  -------------------------------------------------------------------

EPOP -- early postoperative pneumonia.

###### 

Comparison of patients in SIRS and non SIRS groups.

  -------------------------------------------------------------------------------------------------------------
                                            SIRS group\                   Non SIRS group\               *P*
                                            N=112                         N=290                         
  ----------------------------------------- ----------------------------- ----------------------------- -------
  Age (y)                                   63.77±8.89 (42--84)           65.07±8.64 (37--86)           0.180

  ≥70 (n, %)                                33 (29.46)                    93 (32.07)                    0.614

  Female (n, %)                             30 (26.79)                    58 (20.00)                    0.141

  Weight (kg)                               70.13±9.64 (48--100)          69.26±11.20 (45--125)         0.470

  Height (cm)                               166.24±7.81 (146--185)        166.91±7.14 (142--182)        0.415

  BMI (kg/m^2^)                             25.33±2.76 (19.59--33.56)     24.81±3.33 (16.98--38.58)     0.144

  Morbid obesity (n, %)                     112 (100.00)                  132 (45.52)                   0.000

  Body surface area (m^2^)                  1.76±0.16 (1.35--2.19)        1.75±0.17 (1.30--2.55)        0.657

  Diabetes (n, %)                           34 (30.36)                    80 (27.59)                    0.581

  Hypertension (n, %)                       59 (52.68)                    181 (62.41)                   0.075

  Renal failure (n, %)                      1 (0.89)                      1 (0.34)                      0.484

  Serum creatinine (μmol/L)                 77.46±40.71 (29.20--413.70)   77.10±23.58 (36.40--233.60)   0.912

  Ccr (mL/min)                              86.35±29.06 (17.45--231.86)   82.46±29.67 (6.42--246.55)    0.237

  Cerebrovascular accident (n, %)           12 (10.71)                    22 (7.59)                     0.313

  COPD (n, %)                               3 (2.68)                      17 (5.86)                     0.189

  Peripheral vascular disease (n, %)        3 (2.68)                      4 (1.38)                      0.373

  Previous cardiac surgery (n, %)           10 (8.93)                     21 (7.24)                     0.570

  Atrial flutter and fibrillation (n, %)    3 (2.68)                      5 (1.72)                      0.540

  Pulmonary hypertension (n, %)             30 (26.79)                    69 (23.79)                    0.533

  Myocardial infarction (n, %)              11 (9.82)                     25 (8.62)                     0.525

  Unstable angina pectoris (n, %)           47 (41.96)                    139 (47.93)                   

  Number of diseased coronary vessels (n)   2.82±0.49 (1--3)              2.84±0.49 (1--3)              0.373

  Three-vessel coronary disease (n, %)      97 (86.61)                    261 (90.00)                   

  NYHA IV (n, %)                            4 (3.57)                      6 (2.07)                      0.347

  LVEF (%)                                  60.24±9.03 (34.10--71.90)     59.62±8.88 (20.90--73.10)     0.535

  Preoperative IABP (n, %)                  1 (0.89)                      3 (1.03)                      0.713

  Status of surgery                                                                                     0.055

  Elective (n, %)                           99 (88.39)                    273 (94.14)                   

  Urgent (n, %)                             13 (11.61)                    14 (4.83)                     

  Number of grafts (n)                      3.58±1.05 (1--6)              3.62±0.99 (1--6)              0.742

  PCT (ng/ml)                               1.52±2.25 (0.13--13.07)       1.49±3.22 (0.04--40.88)       0.918

  POD1 WBC (×10^3^/uL)                      15.35±3.65 (8.18--26.88)      15.12±4.00 (7.01--36.12)      0.591

  POD2 WBC (×10^3^/uL)                      17.06±4.64 (4.14--27.72)      17.24±4.69 (7.36--33.86)      0.727

  POD3 WBC (×10^3^/uL)                      14.69±4.17 (5.34--27.52)      14.45±4.47 (4.53--32.76)      0.626

  POD1 N ratio (%)                          89.19±3.24 (79.48--96.17)     89.84±3.07 (76.67--97.04)     0.064

  POD2N ratio (%)                           87.53±3.66 (72.22--94.84)     88.32±3.23 (78.06--97.32)     0.036

  POD3 N ratio (%)                          87.66±4.54 (71.86--95.38)     87.49±4.49 (70.01--99.27)     0.724

  PO Temp (°C)                              37.21±0.63 (35.50--38.70)     36.99±0.54 (35.30--38.70)     0.001

  POD1 Temp (°C)                            38.02±0.49 (36.90--40.10)     37.42±0.40 (35.90--38.70)     0.000

  POD2 Temp (°C)                            37.98±0.63 (36.50--39.50)     37.30±0.44 (36.20--38.50)     0.000

  POD3 Temp (°C)                            37.52±0.61 (36.50--39.30)     37.08±0.40 (36.20--38.20)     0.000

  APACHE II score                           19.06±2.14 (14--24)           19.47±1.93 (15--25)           0.067

  EPOP (n, %)                               13 (11.61)                    31 (10.69)                    0.792

  ICU LOS (d)                               2.97±2.60 (1--11)             2.34±2.44 (1--16)             0.023

  Readmission ICU (n, %)                    6 (5.36)                      14 (4.83)                     0.827

  Hospital mortality (n, %)                 4 (3.57)                      7 (2.41)                      0.524
  -------------------------------------------------------------------------------------------------------------

SIRS -- systemic inflammatory response syndrome; BMI -- body mass index; Scr -- serum creatinine; Ccr -- endogenous creatinine clearance rate; COPD -- chronic obstructive pulmonary disease; PCI -- percutaneous coronary intervention; NYHA -- New York Heart Association; LVEF -- left ventricular ejection fraction; PCT -- procalcitonin; POD -- postoperative day; WBC -- white blood cell; N -- neutrophil; PO -- postoperative; Temp -- temperature; APACHE -- Acute Physiology and Chronic Health Evaluation; EPOP -- early postoperative pneumonia; ICU -- intensive care unit; LOS -- length of stay.
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![(**A**) ROC show the value of PCT (value on POD1), WBC (value on POD1), neutrophil ratio (value on POD1), and body temperature (value on POD1) for the diagnosis of EPOP in total patient cohort. (**B**) ROC curves show the value of PCT, WBC, neutrophil ratio, and body temperature for the diagnosis of EPOP in SIRS group. (**C**) ROC curves show the value of PCT, WBC, neutrophil ratio, and body temperature for the diagnosis of EPOP in non-SIRS group. ROC -- receiver operating characteristic; POD -- postoperative day; PCT -- procalcitonin; EPOP -- early postoperative pneumonia; WBC -- white blood cell; SIRS -- systemic inflammatory response syndrome.](medscimonit-25-3077-g001){#f1-medscimonit-25-3077}

![(**A**) Decision curves show the clinical usefulness of PCT, WBC, neutrophil ratio, and body temperature in diagnosis of EPOP in total patient. (**B**) Decision curves show the clinical usefulness of PCT, WBC, neutrophil ratio, and body temperature in diagnosis of EPOP in SIRS group. (**C**) Decision curves show the clinical usefulness of PCT, WBC, neutrophil ratio, and body temperature in diagnosis of EPOP in non-SIRS group. PCT -- procalcitonin; WBC -- white blood cell; EPOP -- early postoperative pneumonia; SIRS -- systemic inflammatory response syndrome.](medscimonit-25-3077-g002){#f2-medscimonit-25-3077}

###### 

Clinical characteristics of 402 consecutive off-pump CABG patients.

                                                  Total (N=402)
  ----------------------------------------------- -----------------------------
  Age (y)                                         64.71±8.72 (37--86)
   \<70 (n,%)                                     276 (68.7)
   ≥70 (n, %)                                     126 (31.3)
  Female (n, %)                                   88 (21.89)
  Weight (kg)                                     69.50±10.78 (45--125)
  Height (cm)                                     166.72±7.33 (142--185)
  BMI (kg/m^2^)                                   24.96±3.19 (16.98--38.58)
  Morbid obesity (n, %)                           244 (60.70)
  Body surface area (m^2^)                        1.75±0.17 (1.30--2.55)
  Diabetes (n, %)                                 114 (28.36)
  Hypertension (n, %)                             240 (59.70)
  Renal failure (n, %)                            2 (0.50)
  Serum creatinine (μmol/L)                       77.20±29.32 (29.20--413.70)
  Endogenous creatinine clearance rate (mL/min)   83.54±29.52 (6.42--246.55)
  Cerebrovascular accident (n, %)                 34 (8.46)
  COPD (n, %)                                     20 (4.98)
  Peripheral vascular disease (n, %)              7 (1.74)
  Previous PCI (n, %)                             31 (7.71)
  Atrial flutter and fibrillation (n, %)          8 (1.99)
  Accompanied by pulmonary hypertension (n, %)    99 (24.63)
  Myocardial infarction (n, %)                    36 (8.96)
  Unstable angina pectoris (n, %)                 186 (46.27)
  Number of diseased coronary vessels (n)         2.84±0.49 (1--3)
  Three-vessel coronary disease (n, %)            358 (89.05)
  NYHA IV (n, %)                                  10 (2.49)
  LVEF (%)                                        59.79±8.91 (20.90--73.10)
  Preoperative IABP (n, %)                        4 (1.00)
  Status of surgery                               
  Elective (n, %)                                 372 (92.54)
  Urgent (n, %)                                   30 (7.46)
  Number of grafts (n)                            3.61±1.01 (1--6)
  PCT (ng/mL)                                     1.50±2.98 (0.04--40.88)
  POD1 WBC (×10^3^/uL)                            15.18±3.90 (7.01--36.12)
  POD2 WBC (×10^3^/uL)                            17.19±4.67 (4.14--33.86)
  POD3 WBC (×10^3^/uL)                            14.52±4.39 (4.53--32.76)
  POD1 neutrophil ratio (%)                       89.66±3.13 (76.67--97.04)
  POD2 neutrophil ratio (%)                       88.10±3.37 (72.22--97.32)
  POD3 neutrophil ratio (%)                       87.54±4.50 (70.01--99.27)
  PO temperature (C)                              37.05±0.58 (35.30--38.70)
  POD1 temperature (C)                            37.59±0.51 (35.90--40.10)
  POD2 temperature (C)                            37.49±0.58 (36.20--39.50)
  POD3 temperature (C)                            37.20±0.51 (36.20--39.30)
  APACHE II score                                 19.36±2.00 (14.00--25.00)
  SIRS (n, %)                                     112 (27.86)
  EPOP (n, %)                                     44 (10.95)
  ICU LOS (d)                                     2.52±2.50 (1--16)
  Readmission ICU (n, %)                          20 (4.98)
  Hospital mortality (n, %)                       11 (2.74)

CABG -- coronary artery bypass grafting surgery; BMI -- body mass index; COPD -- chronic obstructive pulmonary disease; PCI -- percutaneous coronary intervention; NYHA -- New York Heart Association; LVEF -- left ventricular ejection fraction; PCT -- procalcitonin; POD -- postoperative day; WBC -- white blood cell; PO -- postoperative; APACHE -- Acute Physiology and Chronic Health Evaluation; SIRS -- systemic inflammatory response syndrome; EPOP -- early postoperative pneumonia; ICU -- intensive care unit; LOS -- length of stay.

###### 

Comparison of patients in EPOP and non EPOP groups.

  -------------------------------------------------------------------------------------------------------------------
                                                  EPOP group\                   Non EPOP group\               *P*
                                                  N=44                          N=358                         
  ----------------------------------------------- ----------------------------- ----------------------------- -------
  Age (y)                                         66.61±7.64 (48--81)           64.47±8.82 (37--86)           0.124

  ≥70 (n, %)                                      19 (43.18)                    107 (29.89)                   0.073

  Female (n, %)                                   12 (27.27)                    76 (21.23)                    0.361

  Weight (kg)                                     65.92±10.85 (45--97)          69.94±10.70 (47--125)         0.019

  Height (cm)                                     165.80±7.60 (144--182)        166.84±7.30 (142--185)        0.375

  BMI (kg/m^2^)                                   23.96±3.45 (16.98--33.56)     25.08±3.14 (17.72--38.58)     0.028

  Morbid obesity (n, %)                           26 (59.09)                    219 (61.17)                   0.644

  Body surface area (m^2^)                        1.70±0.17 (1.30--2.13)        1.76±0.17 (1.35--2.55)        0.029

  Diabetes (n, %)                                 16 (36.36)                    98 (27.37)                    0.212

  Hypertension (n, %)                             28 (63.64)                    212 (59.22)                   0.573

  Renal failure (n, %)                            1 (2.27)                      1 (0.28)                      0.077

  Serum creatinine (μmol/L)                       83.74±55.91 (29.20--413.70)   76.39±24.14 (36.40--269.00)   0.394

  Endogenous creatinine clearance rate (mL/min)   75.59±34.11 (6.42--231.86)    84.52±28.81 (8.51--246.55)    0.058

  Cerebrovascular accident (n, %)                 5 (11.36)                     29 (8.10)                     0.509

  COPD (n, %)                                     4 (9.09)                      16 (4.47)                     0.184

  Peripheral vascular disease (n, %)              1 (2.27)                      6 (1.68)                      0.775

  Previous PCI (n, %)                             8 (18.18)                     23 (6.42)                     0.006

  Atrial flutter and fibrillation (n, %)          0 (0.00)                      8 (2.23)                      0.317

  Pulmonary hypertension (n, %)                   13 (29.55)                    86 (24.02)                    0.423

  Myocardial infarction (n, %)                    3 (6.82)                      33 (9.22)                     0.752

  Unstable angina pectoris (n, %)                 23 (52.27)                    163 (45.53)                   

  Number of diseased coronary vessels (n)         2.95±0.21 (2--3)              2.82±0.51 (1--3)              0.136

  Three-vessel coronary disease (n, %)            42 (95.45)                    316 (88.27)                   

  NYHA IV (n, %)                                  1 (2.27)                      9 (2.51)                      0.882

  LVEF (%)                                        60.16±8.95 (33.70--72.80)     59.75±8.92 (20.90--73.10)     0.775

  Preoperative IABP (n, %)                        1 (2.27)                      3 (0.84)                      0.998

  Status of surgery                                                                                           0.677

  Elective (n, %)                                 40 (90.91)                    332 (92.74)                   

  Urgent (n, %)                                   4 (9.09)                      23 (6.42)                     

  Number of grafts (n)                            3.75±0.87 (2--5)              3.59±1.02 (1--6)              0.374

  PCT (ng/mL)                                     5.21±7.15 (0.11--40.88)       1.04±1.39 (0.04--13.07)       0.000

  POD1 WBC (×10^3^/uL)                            15.50±4.20 (8.42--26.88)      15.14±3.87 (7.01--36.12)      0.566

  POD2 WBC (×10^3^/uL)                            17.40±4.94 (9.61--30.13)      17.17±4.64 (4.14--33.86)      0.760

  POD3 WBC (×10^3^/uL)                            14.85±5.95 (5.67--32.76)      14.48±4.16 (4.53--28.91)      0.684

  POD1 neutrophil ratio (%)                       89.68±3.77 (81.32--97.04)     89.65±3.04 (76.67--95.95)     0.965

  POD2 neutrophil ratio%)                         89.01±3.47 (78.16--97.32)     87.98±3.34 (72.22--96.91)     0.056

  POD3 neutrophil ratio (%)                       88.94±3.81 (79.83--95.31)     87.36±4.55 (70.01--99.27)     0.027

  PO temperature (C)                              37.12±0.66 (36.20--38.70)     37.04±0.57 (35.30--38.70)     0.480

  POD1 temperature (C)                            37.66±0.55 (36.40--39.00)     37.58±0.50 (35.90--40.10)     0.323

  POD2 Temperature (C)                            37.40±0.62 (36.30--39.30)     37.50±0.58 (36.20--39.50)     0.262

  POD3 temperature (C)                            37.28±0.56 (36.30--39.10)     37.19±0.50 (36.20--39.30)     0.316

  APACHE II score                                 19.80±2.24 (15.00--25.00)     19.30±1.96 (14.00--24.00)     0.168

  SIRS (n, %)                                     13 (29.55)                    99 (27.65)                    0.792

  ICU LOS (d)                                     2.45±2.24 (1--10)             2.53±2.53 (1--16)             0.860

  Readmission ICU (n, %)                          3 (6.82)                      17 (4.75)                     0.552

  Hospital mortality (n, %)                       4 (9.09)                      7 (1.96)                      0.006
  -------------------------------------------------------------------------------------------------------------------

EPOP -- early postoperative pneumonia; BMI -- body mass index; COPD -- chronic obstructive pulmonary disease; PCI -- percutaneous coronary intervention; NYHA -- New York Heart Association; LVEF -- left ventricular ejection fraction; PCT -- procalcitonin; POD -- postoperative day; WBC -- white blood cell; PO -- postoperative; APACHE -- Acute Physiology and Chronic Health Evaluation; SIRS -- systemic inflammatory response syndrome; ICU -- intensive care unit; LOS -- length of stay.

###### 

ROC analysis to diagnosis EPOP in the whole cohort.

                     AUC     95%CI          P value   Cutoff     Sensitivity (%)   Specificity (%)
  ------------------ ------- -------------- --------- ---------- ----------------- -----------------
  PCT (ng/mL)        0.808   0.724--0.891   0.000     \>1.585    73                86
  POD1 WBC           0.519   0.425--0.613   0.682     \>21.425   14                95
  POD2 WBC           0.500   0.403--0.597   0.999     \>20.30    34                79
  POD3 WBC           0.482   0.385--0.580   0.703     \>21.005   16                92
  POD1 neutrophil%   0.500   0.400--0.599   0.996     \>92.111   30                79
  POD2 neutrophil%   0.601   0.513--0.689   0.029     \>88.820   66                59
  POD3 neutrophil%   0.596   0.508--0.683   0.038     \>92.148   30                88
  POD1 temperature   0.557   0.460--0.654   0.217     \>37.75    57                65
  POD2 temperature   0.448   0.356--0.540   0.261     \>38.75    5                 97
  POD3 temperature   0.545   0.454--0.635   0.334     \>37.15    59                52

ROC -- receiver operating characteristic; EPOP -- early postoperative pneumonia; AUC -- area under the curve; CI -- confidence intervals; PCT -- procalcitonin; POD -- postoperative day; WBC -- white blood cell.

###### 

ROC analysis to diagnosis EPOP in SIRS and non SIRS groups.

                       AUC     95%CI            P value   Cutoff     Sensitivity (%)   Specificity (%)
  -------------------- ------- ---------------- --------- ---------- ----------------- -----------------
  **SIRS group**                                                                       
   PCT (ng/mL)         0.868   0.748--0.988     0.000     \>1.775    85                89
   POD1 WBC            0.596   0.406--0.787     0.260     \>17.49    46                80
   POD2 WBC            0.447   0.260--0.634     0.534     \>20.645   31                80
   POD3 WBC            0.426   0.249--0.602     0.386     \>21.745   15                95
   POD1 N%             0.347   0.176--0.519     0.074     \>95.395   8                 100
   POD2 N%             0.577   0.425--0.730     0.366     \>85.96    92                31
   POD3 N%             0.490   0.318--0.661     0.902     \>92.117   23                89
   POD1 temp           0.542   0.384--0.700     0.627     \>37.75    92                28
   POD2 temp           0.406   0.244--0.568     0.272     \>36.85    100               6
   POD3 temp           0.448   0.268--0.628     0.546     \>38.65    15                97
  **Non SIRS group**                                                                   
   PCT (ng/mL)         0.784   0.680--0.889     0.000     \>1.580    68                86
   POD1 WBC            0.487   0.382----0.593   0.820     \>13.35    68                38
   POD2 WBC            0.522   0.409--0.635     0.690     \>20.3     35                79
   POD3 WBC            0.504   0.387--0.621     0.942     \>21.005   16                93
   POD1 N%             0.567   0.454--0.679     0.225     \>92.111   36                79
   POD2 N%             0.613   0.505--0.720     0.040     \>88.812   71                57
   POD3 N%             0.637   0.538--0.735     0.013     \>87.392   77                48
   POD1 temp           0.559   0.435--0.682     0.287     \>37.75    42                79
   POD2 temp           0.433   0.319--0.548     0.224     \>37.95    7                 95
   POD3 temp           0.591   0.479--0.703     0.099     \>37.15    58                61

ROC -- receiver operating characteristic; EPOP -- early postoperative pneumonia; SIRS -- systemic inflammatory response syndrome; AUC -- area under the curve; CI -- confidence intervals; PCT -- procalcitonin; POD -- postoperative day; WBC -- white blood cell; N -- neutrophil; temp -- temperature.
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